Epstein-Barr virus: an important vaccine target for cancer prevention
JI Cohen, AS Fauci, H Varmus, GJ Nabel - Science translational …, 2011 - science.org
JI Cohen, AS Fauci, H Varmus, GJ Nabel
Science translational medicine, 2011•science.orgParticipants at the February 2011 meeting at the US National Institutes of Health on Epstein-
Barr virus (EBV) vaccine research recommend that future clinical trials have two goals:
prevention of infectious mononucleosis and EBV-associated cancers, facilitated by
identification of disease-predictive surrogate markers.
Barr virus (EBV) vaccine research recommend that future clinical trials have two goals:
prevention of infectious mononucleosis and EBV-associated cancers, facilitated by
identification of disease-predictive surrogate markers.
Participants at the February 2011 meeting at the U.S. National Institutes of Health on Epstein-Barr virus (EBV) vaccine research recommend that future clinical trials have two goals: prevention of infectious mononucleosis and EBV-associated cancers, facilitated by identification of disease-predictive surrogate markers.
AAAS